BioCorRx Inc. (BICX)
OTCMKTS
· Delayed Price · Currency is USD
0.4000
+0.0400 (11.11%)
Jun 12, 2025, 3:03 PM EDT
BioCorRx Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -4.71 | -5.11 | -3.77 | -4.37 | -5.21 | -3.47 | Upgrade
|
| Depreciation & Amortization | 0.1 | 0.1 | 0.2 | 0.14 | 0.17 | 0.17 | Upgrade
|
| Other Amortization | 0.97 | 1.1 | 0.64 | 0.49 | 0.48 | 0.48 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.05 | - | 0.14 | - | Upgrade
|
| Stock-Based Compensation | 1.17 | 1.22 | 0.28 | 0.35 | 0.21 | 0.36 | Upgrade
|
| Other Operating Activities | 0.21 | 0.07 | 0.03 | 0.76 | -0.03 | -0.06 | Upgrade
|
| Change in Accounts Receivable | -0.11 | 0 | 0.03 | -0.03 | -0 | 0 | Upgrade
|
| Change in Accounts Payable | 1.13 | 1.44 | 0.8 | 0.84 | 0.7 | 0.48 | Upgrade
|
| Change in Unearned Revenue | 0.05 | 0.05 | -0.03 | -0.03 | -0.13 | -0.04 | Upgrade
|
| Change in Other Net Operating Assets | -0.26 | 0.03 | -0.09 | -0.19 | 0.14 | -0.07 | Upgrade
|
| Operating Cash Flow | -1.45 | -1.1 | -1.85 | -2.04 | -3.54 | -2.15 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0 | -0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -0.05 | - | Upgrade
|
| Investing Cash Flow | - | - | - | - | -0.05 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | 1.13 | 0.97 | 0.78 | 0.7 | 0.01 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.13 | 0.1 | Upgrade
|
| Total Debt Issued | 1.39 | 1.13 | 0.97 | 0.78 | 0.83 | 0.11 | Upgrade
|
| Short-Term Debt Repaid | - | -0.01 | -0.04 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0 | -0 | -0 | - | - | Upgrade
|
| Total Debt Repaid | -0.02 | -0.01 | -0.04 | -0 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 1.37 | 1.12 | 0.93 | 0.77 | 0.83 | 0.11 | Upgrade
|
| Issuance of Common Stock | - | - | 0.92 | 1.25 | 2.25 | - | Upgrade
|
| Financing Cash Flow | 1.37 | 1.12 | 1.85 | 2.02 | 3.08 | 0.11 | Upgrade
|
| Net Cash Flow | -0.08 | 0.02 | -0 | -0.02 | -0.51 | -2.05 | Upgrade
|
| Free Cash Flow | -1.45 | -1.1 | -1.85 | -2.04 | -3.54 | -2.16 | Upgrade
|
| Free Cash Flow Margin | -1040.86% | -14302.07% | -2078.60% | -954.81% | -7332.77% | -1762.42% | Upgrade
|
| Free Cash Flow Per Share | -0.12 | -0.10 | -0.22 | -0.28 | -0.55 | -0.40 | Upgrade
|
| Cash Interest Paid | 0 | 0.01 | 0.02 | - | - | - | Upgrade
|
| Levered Free Cash Flow | 3.52 | -0.72 | -0.88 | -2.01 | -2.06 | -3.53 | Upgrade
|
| Unlevered Free Cash Flow | 3.43 | -0.87 | -0.97 | -1.83 | -2.18 | -3.7 | Upgrade
|
| Change in Net Working Capital | -5.34 | -1.02 | -0.89 | -0.61 | -0.84 | -0.47 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.